FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Longitude Venture Partners L.P. 		2. Issuer Name and Ticker or Trading Symbol

CORCEPT THERAPEUTICS INC [ CORT ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

800 EL CAMINO REAL, SUITE 220,  		3. Date of Earliest Transaction (MM/DD/YYYY)

3/20/2015
(Street)

MENLO PARK, CA 94025
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   3/20/2015     X (2)    634516   A $2.77   13145097   D   (1)  
Common Stock   3/20/2015     S (2)    300447   D $5.85   12844650   D   (1)  
Common Stock   3/20/2015     X (3)    486443   A $2.77   13331093   D   (1)  
Common Stock   3/20/2015     S (3)    230333   D $5.85   13100760   D   (1)  
Common Stock   3/20/2015     X (5)    9750   A $2.77   182742   I   By LCA   (4)
Common Stock   3/20/2015     S (5)    4617   D $5.85   178125   I   By LCA   (4)
Common Stock   3/24/2015     X (6)    1130709   A $2.77   14231469   D   (1)  
Common Stock   3/24/2015     S (6)    554348   D $5.65   13677121   D   (1)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant (Right to Buy)   $2.77   3/20/2015     X   (2)       634516    3/25/2008   3/24/2015   Common Stock   634516   $0   1130709   D   (1)  
Warrant (Right to Buy)   $2.77   3/20/2015     X   (3)       486443    2/6/2009   3/24/2015   Common Stock   486443   $0   0   D   (1)  
Warrant (Right to Buy)   $2.77   3/20/2015     X   (5)       9750    2/6/2009   3/24/2015   Common Stock   9750   $0   0   I   By LCA   (4)
Warrant (Right to Buy)   $2.77   3/24/2015     X   (6)       1130709    3/25/2008   3/24/2015   Common Stock   1130709   $0   0   D   (1)  

Explanation of Responses:
( 1)  Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Venture Partners, L.P. ("LVP"). This report is filed jointly by LVP, Longitude Capital Partners, LLC ("Longitude Capital") and Juliet Tammenoms Bakker with respect to the securities held and transactions effected by LVP. LVP may also be deemed a director by virtue of its right to nominate a representative to serve on the Issuer's Board of Directors. Patrick G. Enright currently serves as LVP's representative on the Issuer's Board of Directors and files separate reports under Section 16(a) of the Securities Exchange Act of 1934 to report transactions in securities of the Issuer. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
( 2)  On March 20, 2015, LVP exercised a warrant to purchase 634,516 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 300,447 of such shares to pay the exercise price and issuing to LVP the remaining 334,069 shares. In connection with such exercise, the Issuer also paid to LVP $5.63 in cash in lieu of a fractional share.
( 3)  On March 20, 2015, LVP exercised a warrant to purchase 486,443 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 230,333 of such shares to pay the exercise price and issuing to LVP the remaining 256,110 shares. In connection with such exercise, the Issuer also paid to LVP $0.94 in cash in lieu of a fractional share.
( 4)  Reflects transactions and holdings of shares of common stock of the Issuer held of record by Longitude Capital Associates, L.P. ("LCA"). This report is jointly filed by LCA, Longitude Capital and Ms. Bakker with respect to the securities held and transactions effected by LCA. Each of Longitude Capital and Ms. Bakker disclaims beneficial ownership of these securities, except to the extent of their respective pecuniary interest therein.
( 5)  On March 20, 2015, LCA exercised a warrant to purchase 9,750 shares of the Issuer's common stock for an exercise price of $2.77 per share. LCA paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 4,617 of such shares to pay the exercise price and issuing to LCA the remaining 5,133 shares. In connection with such exercise, the Issuer also paid to LCA $1.95 in cash in lieu of a fractional share.
( 6)  On March 24, 2015, LVP exercised a warrant to purchase 1,130,709 shares of the Issuer's common stock for an exercise price of $2.77 per share. LVP paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 554,348 of such shares to pay the exercise price and issuing to LVP the remaining 576,361 shares. In connection with such exercise, the Issuer also paid to LVP $2.27 in cash in lieu of a fractional share.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Longitude Venture Partners L.P.
800 EL CAMINO REAL, SUITE 220
MENLO PARK, CA 94025 		X X

Longitude Capital Associates, L.P.
800 EL CAMINO REAL, SUITE 220
MENLO PARK, CA 94025
X

Longitude Capital Partners, LLC
800 EL CAMINO REAL, SUITE 220
MENLO PARK, CA 94025
X

Tammenoms Bakker Juliet
C/O LONGITUDE CAPITAL PARTNERS, LLC
800 EL CAMINO REAL, SUITE 220
MENLO PARK, CA 94025
X


Signatures
/s/ Juliet Tammenoms Bakker, as managing member ofLongitude Capital Partners, LLC, as general partner ofLongitude Venture Partners, L.P 3/24/2015
** Signature of Reporting Person Date

/s/ Juliet Tammenoms Bakker, as managing member ofLongitude Capital Partners, LLC, as general partner ofLongitude Capital Associates, L.P. 3/24/2015
** Signature of Reporting Person Date

/s/ Juliet Tammenoms Bakker, as managing member ofLongitude Capital Partners, LLC 3/24/2015
** Signature of Reporting Person Date

/s/ Juliet Tammenoms Bakker 3/24/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Corcept Therapeutics Charts.
Corcept Therapeutics (NASDAQ:CORT)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Corcept Therapeutics Charts.